KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Well (AMWL) Cash & Equivalents (2018 - 2025)

Historic Cash & Equivalents for American Well (AMWL) over the last 8 years, with Q4 2025 value amounting to $182.3 million.

  • American Well's Cash & Equivalents fell 2014.23% to $182.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $182.3 million, marking a year-over-year decrease of 2014.23%. This contributed to the annual value of $182.3 million for FY2025, which is 2014.23% down from last year.
  • Per American Well's latest filing, its Cash & Equivalents stood at $182.3 million for Q4 2025, which was down 2014.23% from $200.9 million recorded in Q3 2025.
  • American Well's 5-year Cash & Equivalents high stood at $975.2 million for Q2 2021, and its period low was $112.9 million during Q1 2023.
  • Over the past 5 years, American Well's median Cash & Equivalents value was $267.0 million (recorded in 2022), while the average stood at $378.1 million.
  • In the last 5 years, American Well's Cash & Equivalents surged by 62385.77% in 2021 and then tumbled by 8026.13% in 2022.
  • Over the past 5 years, American Well's Cash & Equivalents (Quarter) stood at $746.4 million in 2021, then decreased by 27.85% to $538.5 million in 2022, then crashed by 30.92% to $372.0 million in 2023, then plummeted by 38.63% to $228.3 million in 2024, then decreased by 20.14% to $182.3 million in 2025.
  • Its Cash & Equivalents was $182.3 million in Q4 2025, compared to $200.9 million in Q3 2025 and $219.1 million in Q2 2025.